KA
AGN

Klingman & Associates’s Allergan plc AGN Stock Holding History

Klingman & Associates’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-262
Closed -$60K – 347
2016
Q3 		$60K Buy
262
+53
+25% +$13K 0.02% 174
2016
Q2 		$48K Hold
209
– – 0.02% 192
2016
Q1 		$56K Buy
+209
New +$59.8K 0.02% 184
2015
Q4 		– Sell
-222
Closed -$60K – 437
2015
Q3 		$60K Sell
222
-27
-11% -$8.29K 0.02% 200
2015
Q2 		$76K Buy
+249
New +$74.3K 0.03% 155

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Klingman & Associates's AGN Position: Q4 2016 in Review

Klingman & Associates sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 262 shares — an estimated $60K sold.

Klingman & Associates first reported a position in AGN in Q2 2015 and held it in 5 quarters. The position peaked at $76K in Q2 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Klingman & Associates reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Klingman & Associates sold 262 Allergan plc shares in Q4 2016, an estimated $60K.
  • Klingman & Associates first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Klingman & Associates's Allergan plc position peaked at $76K in Q2 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.